Recent top news in dry eye coverage
Click Here to Manage Email Alerts
Options for dry eye treatment secondary to glaucoma and a conversation from dry eye experts lead recent dry eye disease coverage.
See more recent items covering dry eye disease below.
Options available, on the way to treat dry eye secondary to glaucoma
Dry eye disease and glaucoma both increase in prevalence with age. They are also commonly present in the patient who presents for cataract surgery. Read more.
VIDEO: Matossian, White discuss dry eye flare-ups, part 2
In this second video in their ongoing discussion of dry eye, Cynthia A. Matossian, MD, and Darrell E. White, MD, discuss common and some not-so-common triggers for dry eye flare-ups. Watch more.
Phase 3 trial of reproxalap for dry eye disease treatment underway
The first patient has been enrolled in the phase 3 TRANQUILITY trial evaluating reproxalap for the treatment of patients with dry eye disease. Read more.
Novaliq initiates patient randomization in CyclASol phase 3 trial
Novaliq has started the randomization of patients in ESSENCE-2, a phase 3 clinical trial of CyclASol, a topical anti-inflammatory and immunomodulating ophthalmic solution for the treatment of dry eye disease. Read more.
Bausch launches second phase 3 study of NOV03 for dry eye disease
The second of two phase 3 studies evaluating NOV03 as a first-in-class investigational drug for treatment of signs and symptoms of dry eye disease associated with meibomian gland dysfunction has been initiated. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts